effectiveness of semaglutide vs Tirzepatide: Which GLP-1 Wins for Weight Loss? Effectiveness of Oral versus Injectable

TRIUMPH 1, 2 & 3 are all 80-week trials so they will show EVEN more weight loss which is almost hard to fathom

As the regional director for clinical nutrition and weight management

Both compounds benefit from before-and-after progress photos taken under consistent lighting and conditions

eligible Medicare patients can access FDA-approved GLP-1 medications for $50/month through the CMS Medicare GLP-1 Bridge Program - a different pathway worth evaluating before enrolling in a cash-pay compounded program FDA adverse event data (as of May 21, 2026): FDA had received more than 1,700 adverse events associated with compounded semaglutide and tirzepatide combined - a safety signal not specific to Omzo but material context for any compounded GLP-1 enrollment decision